News
SDZXF
81.25
NaN%
--
Barclays Sticks to Its Buy Rating for Sandoz Group Ltd (SDZXF)
TipRanks · 3d ago
Sandoz reiterates FY 2026 constant-currency sales growth outlook of mid-to-high single digits in pre-close brief
PUBT · 4d ago
UPDATE 1-Hybio's generic weight-loss drug set for FDA review
Reuters · 4d ago
Sandoz announces U.S. FDA accepted for review two ANDAs for tirzepatide
TipRanks · 5d ago
FDA set to review Sandoz's generic GLP-1s
Reuters · 5d ago
Viatris Soared 54%: Time To Be More Careful (Rating Downgrade)
Seeking Alpha · 06/23 16:55
Sandoz maps biosimilars ‘golden decade’ with capital markets day and Slovenia hub visit
TipRanks · 06/22 05:35
Sandoz to host capital markets day for investors and analysts
PUBT · 06/22 05:00
Sandoz opens flagship biosimilar R&D hub in Slovenia to anchor $1.1bn expansion
TipRanks · 06/17 05:32
FACTBOX-Major investment pledges at Choose France summit
Reuters · 06/01 13:35
PRESS DIGEST-Financial Times - June 1
Reuters · 05/31 23:58
Sandoz marks 80 years of European antibiotics and urges EU action to protect supply
TipRanks · 05/28 05:32
Biogen faces Italian antitrust probe over rivalry with Sandoz for MS drugs
Seeking Alpha · 05/27 11:27
Italy's antitrust regulator opens probe into US Biogen over alleged dominant position
Reuters · 05/27 06:23
Hims & Hers launches generics for Novo’s semaglutide in Canada
Seeking Alpha · 05/21 13:29
Sandoz confirms the EC granted marketing authorization for Bysumlog, Dazparda
TipRanks · 05/15 12:01
Sandoz wins EU approval for two insulin biosimilars, bolstering diabetes push
TipRanks · 05/15 11:35
Analysts Offer Insights on Healthcare Companies: Siemens Healthineers AG (OtherSEMHF) and Sandoz Group Ltd (OtherSDZXF)
TipRanks · 05/13 01:40
Dr. Reddy’s to become first to sell Ozempic generics in Canada
Seeking Alpha · 05/12 18:46
Analysts Are Bullish on Top Healthcare Stocks: uniQure (QURE), Sandoz Group Ltd (SDZXF)
TipRanks · 05/07 01:50
More
Webull provides a variety of real-time SDZXF stock news. You can receive the latest news about Sandoz Group AG through multiple platforms. This information may help you make smarter investment decisions.
About SDZXF
Sandoz Group AG is a Switzerland based company which is active in healthcare technology industry. The Company operates in two businesses, Generics and Biosimilars. Generics business develops, manufacture and market active ingredients and finished dosage forms of small molecule pharmaceuticals, finished dosage forms of anti-infectives and active pharmaceutical ingredients and intermediates. Biosimilars business develops, manufacture and market protein-based and other biological products which are similar to another already approved biological medicines. Company’s product portfolio comprising Generics and Biosimilars covers all therapeutic areas for patient treatment such as cardiovascular, central nervous system, oncology, anti-infectives, pain and respiratory. The Company serves customers worldwide.